What is the recommended treatment for Lyme disease in children under 9 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Lyme Disease in Children Under 9 Years Old

For children under 9 years old with Lyme disease, amoxicillin at 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days (range 10-21 days) is the recommended first-line treatment. 1

First-Line Treatment Options

For early Lyme disease (characterized by erythema migrans):

  • Amoxicillin: 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days (range 10-21 days) 1
  • Cefuroxime axetil: 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days (range 10-21 days) 1

Age-Specific Considerations

  • Children under 8 years: Doxycycline is traditionally avoided due to concerns about dental staining 2
  • Children 8 years and older: Doxycycline can be used at 4 mg/kg/day in 2 divided doses (maximum 100 mg per dose) 1

Treatment Based on Disease Manifestation

Early Localized Disease (Erythema Migrans)

  • Oral antibiotics for 14 days (range 10-21 days) 1
  • Amoxicillin has shown 100% resolution of constitutional symptoms in clinical studies 3

Neurological Manifestations

  • Facial nerve palsy without CSF abnormalities: Oral regimen as for erythema migrans for 14 days 1
  • Meningitis or radiculopathy: IV ceftriaxone or cefotaxime (parenteral therapy) 1
  • Facial nerve palsy with CSF abnormalities: Treatment as for meningitis 1

Dosing Optimization

Recent pharmacokinetic modeling suggests that amoxicillin at 25 mg/kg/dose given twice daily (q12h) may provide comparable drug exposure to the traditional three-times-daily regimen for MICs between 0.06 and 1 mg/L, which could improve adherence 4. However, the current IDSA guideline still recommends the three-times-daily dosing schedule 1.

Important Clinical Considerations

  • Macrolide antibiotics are not recommended as first-line therapy due to lower efficacy 1
  • First-generation cephalosporins should be avoided 1
  • Treatment duration should not exceed recommended guidelines without clear evidence of treatment failure 1, 5
  • Studies show that a 14-day course of amoxicillin is highly effective for early Lyme disease 6

Emerging Evidence on Doxycycline in Young Children

While traditionally avoided in children under 8 years, recent research suggests doxycycline may be generally well-tolerated and effective in young children with Lyme disease 2. However, amoxicillin remains the preferred treatment for non-neurological manifestations in this age group until more definitive evidence is available 2.

Common Pitfalls to Avoid

  • Extending antibiotic treatment beyond recommended durations 1
  • Using first-generation cephalosporins, which are ineffective 1
  • Attributing persistent symptoms to active infection requiring additional antibiotics 1, 5
  • Confusing Post-Lyme Disease Syndrome with need for additional antibiotic therapy 1

Treatment Monitoring

  • Follow-up evaluations should assess resolution of erythema migrans and constitutional symptoms
  • Complete resolution of erythema migrans occurs in approximately 67-92% of patients after treatment completion 3
  • Most patients have good outcomes with no long-term problems associated with Lyme disease when treated appropriately 3

References

Guideline

Lyme Disease Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Doxycycline for the Treatment of Lyme Disease in Young Children.

The Pediatric infectious disease journal, 2023

Research

Efficacy of a 14-day course of amoxicillin for patients with erythema migrans.

Diagnostic microbiology and infectious disease, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.